Gold was a topper, helped by global pessimism In debt, AAA rated/PSU funds delivered while credit funds were battered In equities, large-cap and multi-cap funds
The market is at a new high. Should I invest a lumpsum in equities today? To answer this question, savvy investors look at the Nifty50’s PE ratio published by the exchange. But before making such drastic decisions based on this lone indicator, it is important to dig deeper into the Nifty50’s published PE.
L&T Finance, a non-deposit-taking NBFC, is seeking to raise Rs 1,500 crore from a public issue of Non-Convertible Debentures that is open from December 16 to December 30, 2019. Should you buy? If so, which option can you consider?
The over 92,000 staffers who have opted for the Voluntary Retirement Scheme (VRS) from BSNL and MTNL are now faced with the challenging task of finding a safe parking ground for their money while making sure it earns reasonable income in a low interest rate environment. They need to factor in liquidity and tax efficiency too. If you’re a VRS optee, don’t worry. Here’s a list of attractive investment options, ranked in the order of their safety.
As the Monetary Policy Committee (MPC) decided to defy all expectations to hold its repo rates at 5.15 per cent yesterday, a sigh of relief must have gone around retirees and fixed deposit investors. But as the MPC has kept the door open for further cuts by signalling an ‘accommodative stance’, they must be wondering – “Is this rock-bottom for interest rates? How much lower can they go?”
“Is my fixed deposit with so-and-so company safe?” This query is cropping up often, after the recent default on fixed deposit repayments by Dewan Housing Finance Limited and RBI’s strictures on PMC Bank.
At PrimeInvestor, our approach to curating a list of fixed deposits is to put safety far ahead of return considerations. Here’s the approach we use to choose our recommended list of FDs.
As some categories of active funds in India such as large-cap funds, have struggled to beat the sprinting Nifty50 and Sensex30 in the last couple of years, there’s a surge of interest in index investing.
But are there risks in index investing that investors are ignoring? Read on to find out.
Most of us buy insurance to make sure that our finances, or those of our dependants, are protected from fate’s sudden googlies. But what if the insurance company you’re relying on is in a shaky financial situation? This risk is not an outlandish one in India.
Recently, IRDA (Insurance Regulatory and Development Authority) asked Reliance Health Insurance Company to stop selling new health policies and to transfer its older policies to Reliance General Insurance Company, after finding that it was unable to maintain its solvency margins at statutory levels. In June 2017, IRDA had ordered Sahara Life Insurance to stop issuing new life policies and had directed its takeover by ICICI Prudential Life Insurance. The order was later overturned by SAT.
If you’re looking to buy a life or a general insurance policy, it is best to vet your insurer before signing up to avoid such uncertainties. What are the checks you can run to ensure that your insurer is in it for the long haul?
LIC’s annual bonuses come out of the valuation surpluses in policyholders’ funds. They are not guaranteed They are simple additions to your account and don’t
If you’re sick and tired of relatives, friends and neighbours badgering you to buy insurance, you may be surprised to know that there’s one type
Public offers of NCDs (Non-Convertible Debentures) from Non-Banking Finance Companies and Housing Finance Companies have been quite a hit with retail investors lately, with the
The purpose of these disclosures is to provide essential information about the Research Services in a manner to assist and enable the prospective client/client in making an informed decision for engaging in Research services before onboarding. History, Present business and Background: PrimeInvestor Financial Research Private Limited is registered with SEBI as Research Analyst with registration no. INH200008653. The Research Analyst got its registration on August 19, 2021 and is engaged in offering research and recommendation services. Terms and conditions of Research Services: The Research Services will be limited to providing independent research recommendation and shall not be involved in any advisory or portfolio allocation services. The Research Analyst never guarantees the returns on the recommendation provided. Investor shall take note that Investment/trading in stocks/Index or other securities is always subject to market risk. Past performance is never a guarantee of same future results. The Research Analyst shall not be responsible for any loss to the Investors. Disciplinary history: There are no pending material litigations or legal proceedings against the Research Analyst. As on date, no penalties / directions have been issued by SEBI under the SEBI Act or Regulations made there under against the Research Analyst relating to Research Analyst services. Details of its associates: No associates. Disclosures with respect to Research and Recommendations Services: The Research Analyst or its directors or any of its officer/employee does not trade in securities which are subject matter of recommendation. There are no actual or potential conflicts of interest arising from any connection to or association with any issuer of products/ securities, including any material information or facts that might compromise its objectivity or independence in the carrying on of Research Analyst services. Such conflict of interest shall be disclosed to the client as and when they arise. Research Analyst or its directors or its employee or its associates have not received any compensation from the company which is subject matter of recommendation. Research Analyst or its directors or its employee or its associates have not managed or co-managed the public offering of any company. Research Analyst or its directors or its employee or its associates have not received any compensation for investment banking or merchant banking of brokerage services from the subject company. Research Analyst or its directors or its employee or its associates have not received any compensation for products or services other than above from the subject company. Research Analyst or its directors or its employee or its associates have not received any compensation or other benefits from the Subject Company or 3rd party in connection with the research report/ recommendation. The subject company was not a client of Research Analyst or its directors or its employee or its associates during twelve months preceding the date of recommendation services provided. Research Analysts or its directors or its employee or its associates has not served as an officer, director or employee of the subject company. Research Analysts has not been engaged in market making activity of the subject company.
Full disclosures and disclaimers
Compliance Officer Details: Name: Srikanth Meenakshi; Email: contact@primeinvestor.
Grievance Officer Details: Name: Srikanth Meenakshi; Email: contact@primeinvestor.
